Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-73-2021
© Author(s) 2021. This work is distributed under the Creative Commons Attribution 4.0 License.
Original full-length article
| 
12 Jan 2021
Original full-length article |
| 12 Jan 2021
| 12 Jan 2021
Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience
Related authors
Related subject area
Subject: Bone substitutes | Topic: All topics
Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study
J. Bone Joint Infect., 6, 413–421, 2021
Cited articles
Auregan, J. C. and Begue, T.: Bioactive glass for long bone infection: a
systematic review, Injury, 46, Suppl 8, S3–7, https://doi.org/10.1016/S0020-1383(15)30048-6, 2015.
Bortolin, M., Romano, C. L., Bidossi, A., Vecchi, E., Mattina, R., and Drago,
L.: BAG-S53P4 as bone graft extender and antimicrobial activity against
gentamicin- and vancomycin-resistant bacteria, Future Microbiol., 13, 525–533,
https://doi.org/10.2217/fmb-2016-0171, 2018.
Calori, G. M., Mazza, E., Colombo, M., and Ripamonti, C.: The use of
bone-graft substitutes in large bone defects: any specific needs?, Injury, 42,
Suppl 2, S56–63, https://doi.org/10.1016/j.injury.2011.06.011, 2011.
Coraca-Huber, D. C., Fille, M., Hausdorfer, J., Putzer, D., and Nogler, M.:
Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms
grown on titanium discs in vitro, J. Orthop. Res., 32, 175–177, https://doi.org/10.1002/jor.22463, 2014.
Cunha, M. T., Murca, M. A., Nigro, S., Klautau, G. B., and Salles, M. J. C.:
In vitro antibacterial activity of bioactive glass S53P4 on multiresistant
pathogens causing osteomyelitis and prosthetic joint infection, BMC Infect
Dis., 18, 157, https://doi.org/10.1186/s12879-018-3069-x, 2018.
